This type of perturbations are being widely studied along with DNA repair deficiencies in different cancers, receiving the name of “BRCAness”, as it was first described with the discovery of BRCA gene mutations in breast tumors, which were highly sensitive to PARP inhibitors [117,118]. Here, PARP1 is linked to cancer.